Neuromodulation for Lennox-Gastaut Syndrome: Interview with Martha Morrell, M.D., CMO of NeuroPace NeuroPace, a medtech company based in California, has developed the RNS system, an implantable neuromodulation device for focal drug-resistant epilepsy. The system continuously monitors brain activity and then responds appropriately to target the seizure source in the brain for personalized seizure prevention. The company reports that the stimulation provided by the device is imperceptible to […]
https://www.medgadget.com/2021..../08/neuromodulation-